Founded in May 2017 and based at the Babraham Research Campus in Cambridge, PredictImmune develops pioneering tools for guiding treatment options in immune-mediated inflammatory diseases like Crohn’s and ulcerative colitis (IBD).
Based on ten years of research at Cambridge University, PredictImmune’s test kits help both clinicians and patients to understand, at the point of diagnosis, the likely course of disease and opens the possibility of better treatment choices from the outset.
Business funding insights
Founder Q&A: from bootstrapping to blooming growth
The founder of Bloom Procurement explains his vision for the business, why he chose BGF funding, and what he learned from the process
Why Northern Irish businesses are growing with buy-and-build strategies
Business in Northern Ireland are in a great position to expand by acquisitions using a buy-and-build strategy, says Chris Nixon, investor.